Of Interest

The incidence rates per 1 million person-years among pediatric and adolescent/young adult patients were 1.74 and 62.05.

Evan Lipson, MD, an associate professor of oncology at John Hopkins School of Medicine and a head and neck oncologist at John Hopkins Medicine, discusses feedback he’s received from colleagues at Case-Based Roundtable events about patients with melanoma.

CHARLOTTESVILLE, Va. (WRIC) — A research team at UVA Health System is pioneering a new approach to treating melanoma, one of the deadliest forms of skin cancer.

Melanoma arising from pigment-producing cells known as melanocytes is the deadliest form of skin cancer. A major cause of melanoma is excessive exposure to ultraviolet light, from sunlight or other sources, which can trigger mutations that promote tumor formation.